HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leticia Oliveira-Ferrer Selected Research

Tubulin

9/2020Tubulin Tyrosine Ligase Like 4 (TTLL4) overexpression in breast cancer cells is associated with brain metastasis and alters exosome biogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leticia Oliveira-Ferrer Research Topics

Disease

37Neoplasms (Cancer)
04/2024 - 12/2004
18Breast Neoplasms (Breast Cancer)
12/2023 - 01/2013
15Neoplasm Metastasis (Metastasis)
01/2024 - 06/2014
14Ovarian Neoplasms (Ovarian Cancer)
01/2024 - 06/2017
5Ovarian Epithelial Carcinoma
01/2022 - 01/2016
4Triple Negative Breast Neoplasms
03/2023 - 01/2019
4Carcinoma (Carcinomatosis)
01/2018 - 06/2014
3Brain Neoplasms (Brain Tumor)
01/2023 - 01/2017
2Lymphatic Metastasis
11/2023 - 06/2017
2Residual Neoplasm
01/2023 - 01/2022
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 01/2021
2Glioma (Gliomas)
11/2013 - 12/2008
2Glioblastoma (Glioblastoma Multiforme)
11/2013 - 12/2012
2Urinary Bladder Neoplasms (Bladder Cancer)
11/2005 - 12/2004
1Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2022
1Uterine Cervical Dysplasia
08/2022
1Ascites
12/2021
1Vulvar Neoplasms (Vulvar Cancer)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Cystadenoma
11/2018
1Disease Progression
11/2018
1Teratoma (Teratoid Tumor)
02/2018
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2018

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2024 - 11/2005
10Messenger RNA (mRNA)IBA
01/2023 - 06/2015
6EnzymesIBA
01/2022 - 06/2014
6Polysaccharides (Glycans)IBA
01/2020 - 06/2014
5IntegrinsIBA
01/2023 - 12/2008
4Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2005
4CEACAM1 ProteinIBA
01/2018 - 12/2004
3Phenobarbital (Luminal)FDA Link
03/2023 - 11/2005
3Small Interfering RNA (siRNA)IBA
01/2023 - 12/2004
3Hyaluronic Acid (Hyaluronan)IBA
11/2022 - 01/2017
3Cell Adhesion Molecule-1IBA
08/2022 - 01/2005
3Angiogenesis InhibitorsIBA
01/2022 - 07/2006
3PlatinumIBA
01/2022 - 10/2017
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 12/2004
3Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
01/2020 - 01/2013
3MicroRNAs (MicroRNA)IBA
01/2019 - 01/2018
2Bevacizumab (Avastin)FDA Link
11/2023 - 01/2022
2SelectinsIBA
01/2023 - 11/2017
2RNA (Ribonucleic Acid)IBA
11/2022 - 06/2014
2LigandsIBA
11/2022 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
08/2022 - 01/2021
2Vascular Endothelial Growth Factor CIBA
01/2022 - 06/2017
2E-SelectinIBA
01/2020 - 01/2013
2Cell Adhesion MoleculesIBA
01/2020 - 11/2017
2MannosidasesIBA
11/2019 - 01/2018
2kifunensineIBA
11/2019 - 01/2018
2Glycoproteins (Glycoprotein)IBA
11/2018 - 11/2009
2Peptide Hydrolases (Proteases)FDA Link
01/2017 - 01/2016
2Complementary DNA (cDNA)IBA
01/2017 - 11/2013
2Cadherins (E-Cadherin)IBA
01/2016 - 09/2015
2EndostatinsIBA
11/2013 - 07/2006
2Orosomucoid (Seromucoid)IBA
11/2009 - 11/2005
2Carcinoembryonic AntigenIBA
12/2007 - 01/2005
1Fumarate Hydratase (Fumarase)IBA
01/2024
1Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2024
1Adenosine Triphosphate (ATP)IBA
01/2024
1Monoclonal AntibodiesIBA
01/2024
1Chaperonin 60IBA
01/2024
1Oncogene Proteins (Oncogene Protein)IBA
12/2023
1Transcription Factors (Transcription Factor)IBA
12/2023
1Type I Tumor Necrosis Factor ReceptorsIBA
12/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2023
1Angiopoietin-2IBA
11/2023
1DesmocollinsIBA
03/2023
1ChemokinesIBA
01/2023
1P-SelectinIBA
01/2023
1Hyaluronan ReceptorsIBA
11/2022
1hydrogen sulfite (bisulfite)IBA
08/2022
1Cell-Free Nucleic AcidsIBA
08/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022
1Cysteine (L-Cysteine)FDA Link
01/2022
1ImmunosorbentsIBA
01/2022
1NAD (NADH)IBA
12/2021
1Metformin (Glucophage)FDA LinkGeneric
12/2021
1Circulating Tumor DNAIBA
12/2021
1tyrosyltubulin ligaseIBA
09/2020
1TubulinIBA
09/2020
1Protein Isoforms (Isoforms)IBA
01/2020
1Immunoglobulin G (IgG)IBA
01/2020
1C-Type Lectins (C-Type Lectin)IBA
01/2019
1Long Noncoding RNAIBA
01/2019
1afimoxifene (hydroxytamoxifen)IBA
01/2019
1SialyltransferasesIBA
11/2018
1Cytoskeletal ProteinsIBA
11/2018
1Tumor Biomarkers (Tumor Markers)IBA
11/2018
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
02/2018
1alpha-Mannosidase (LAMAN)IBA
01/2018
1ProgesteroneFDA LinkGeneric
01/2018
1Estrogens (Estrogen)FDA Link
01/2018
1Actins (F Actin)IBA
12/2017

Therapy/Procedure

11Therapeutics
11/2023 - 12/2004
3Drug Therapy (Chemotherapy)
01/2022 - 10/2017
2Radiotherapy
01/2023 - 01/2021
1Injections
04/2024
1Immunotherapy
01/2023
1Neoadjuvant Therapy
01/2022